Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: February 10, 2020
Context: The filing discloses the pricing of a public offering of units. The registrant files annual reports on Form 20-F.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a capital raise.
- Offering Size: 3,333,334 units
- Price per Unit: $1.50
- Total Gross Proceeds: $5,000,001 (Calculated: 3,333,334 units x $1.50)
Material Changes
The primary material change is the execution of a public offering to raise capital. No comparative financial data or changes in operating metrics versus prior periods are provided in this specific filing.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference a press release (Exhibit 99.1) regarding the offering pricing but does not contain detailed management commentary, forward-looking guidance, or specific risk factors within the body of this Form 6-K text.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and offering expenses (not stated in this text).
- Review the attached Press Release (Exhibit 99.1) for the intended use of proceeds.
- Confirm the composition of the "units" (e.g., whether they include warrants or other securities) as the text does not specify the unit structure.
- Check subsequent filings for the closing date of the offering and actual cash received.